Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes von Shiramoto, Masanari, Nasu, Risa, Oura, Tomonori, Imori, Makoto, Ohwaki, Kenji

Volltext

Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan von Onishi, Yukiko, Oura, Tomonori, Matsui, Akiko, Matsuura, Jun, Iwamoto, Noriyuki

Volltext

Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes von Onishi, Yukiko, Oura, Tomonori, Nishiyama, Hiroshi, Ohyama, Sumika, Takeuchi, Masakazu, Iwamoto, Noriyuki

Volltext

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From... von Inagaki, Nobuya, MD, PhD, Atsumi, Yoshihito, MD, PhD, Oura, Tomonori, MSc, Saito, Hitoshi, PhD, Imaoka, Takeshi, MD, PhD

Volltext

A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial von Emoto, Masanori, Terauchi, Yasuo, Ozeki, Akichika, Oura, Tomonori, Takeuchi, Masakazu, Imaoka, Takeshi

Volltext

Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diab... von Kaneko, Shizuka, Oura, Tomonori, Matsui, Akiko, Shingaki, Tomotaka, Takeuchi, Masakazu

Volltext

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and plac... von Suzuki, Shuichi, Oura, Tomonori, Takeuchi, Masakazu, Boye, Kristina S

Volltext

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer von Yamamura, Shogo, Matsumura, Noriomi, Mandai, Masaki, Huang, Zhiqing, Oura, Tomonori, Baba, Tsukasa, Hamanishi, Junzo, Yamaguchi, Ken, Kang, Hyun Sook, Okamoto, Takako, Abiko, Kaoru, Mori, Seiichi, Murphy, Susan K., Konishi, Ikuo

Volltext

Pancreatic safety in Japanese patients with type 2 diabetes treated with once weekly dulaglutide 0.75 mg up to 52 weeks in phase 3 clinical trials von Emoto, Masanori, Oura, Tomonori, Matsui, Akiko, Kazama, Hirotaka, Iwamoto, Noriyuki

Volltext

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling von Matsumura, Noriomi, Mandai, Masaki, Okamoto, Takako, Yamaguchi, Ken, Yamamura, Shogo, Oura, Tomonori, Baba, Tsukasa, Hamanishi, Junzo, Kang, Hyun S., Matsui, Shigeyuki, Mori, Seiichi, Murphy, Susan K., Konishi, Ikuo

Volltext

Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase... von Inagaki, Nobuya, Takeuchi, Masakazu, Oura, Tomonori, Imaoka, Takeshi, Seino, Yutaka

Volltext

Sample sizes for a robust ranking and selection of genes in microarray experiments von Matsui, Shigeyuki, Oura, Tomonori

Volltext

Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis o... von Osonoi, Takeshi, Oura, Tomonori, Hirase, Tetsuaki

Volltext

Change in pharmacodynamic variables following once‐weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J‐mono substudy) von Yabe, Daisuke, Kawamori, Dan, Seino, Yusuke, Oura, Tomonori, Takeuchi, Masakazu

Volltext

A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes von Furihata, Kenichi, Mimura, Hanaka, Urva, Shweta, Oura, Tomonori, Ohwaki, Kenji, Imaoka, Takeshi

Volltext

802-P: Safety, Pharmacokinetics, and Pharmacodynamics of Once-Weekly Basal Insulin Fc (BIF) in Japanese Patients with Type 2 Diabetes: A Phase 1 Open-Label, Randomized, Active-Cont... von NASU, RISA, OURA, TOMONORI, OHWAKI, KENJI, IMORI, MAKOTO, FURIHATA, KENICHI

Volltext

Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis von Onishi, Yukiko, Oura, Tomonori, Takeuchi, Masakazu

Volltext

Cancer Outlier Analysis Based on Mixture Modeling of Gene Expression Data von Mori, Keita, Oura, Tomonori, Noma, Hisashi, Matsui, Shigeyuki

Volltext

Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diab... von Shizuka Kaneko, Tomonori Oura, Akiko Matsui, Tomotaka Shingaki, Masakazu Takeuchi

Volltext

Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial von Ishii, Hitoshi, Oura, Tomonori, Takeuchi, Masakazu

Volltext